4//SEC Filing
FAHIM RAAFAT E F 4
Accession 0001455244-09-000024
CIK 0000072444other
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 3:14 PM ET
Size
7.4 KB
Accession
0001455244-09-000024
Insider Transaction Report
Form 4
FAHIM RAAFAT E F
DirectorPresident, CEO and CFO
Transactions
- Award
Common Stock
2009-04-01+45,000→ 270,063.534 total - Award
Stock Option (Right to Buy)
2009-04-01+115,000→ 115,000 totalExercise: $3.78Exp: 2016-04-01→ Common Stock (115,000 underlying)
Footnotes (2)
- [F1]Restricted Stock which vests in four equal annual installments beginning on April 1, 2010.
- [F2]The Option will become exercisable in four equal annual installments beginning on April 1, 2010.
Documents
Issuer
NABI BIOPHARMACEUTICALS
CIK 0000072444
Entity typeother
Related Parties
1- filerCIK 0001271999
Filing Metadata
- Form type
- 4
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 3:14 PM ET
- Size
- 7.4 KB